Clarivate (CLVT) just released a dense earnings update. Third quarter revenue came in at US$481.6 million, alongside a higher net loss, fresh impairment charges of US$62.2 million, and guidance that still points to full year losses.
Clarivate's earnings release and fresh impairments landed after a sharp rebound in the share price, with a 30 day share price return of 48.45% and a 90 day gain of 28.49%, hinting at building short term momentum even as the 1 year total shareholder return is still down 33.24%.
Scan how Clarivate stacks up against other information and AI data plays by reviewing our curated list of 42 profitable AI stocks that aren't just burning cash.
Clarivate looks like a serious data and IP franchise, yet the shares just jumped almost 50% in a month while the business still reports losses and fresh impairments. Is that rebound pricing in too much or not enough?
Most Popular Narrative: 21% Undervalued
Clarivate closed at $2.39 while the analyst consensus Narrative on Simply Wall St points to a fair value near $3.04, implying a material gap that hinges on how recurring revenue, margins and debt reduction play out over time.
Clarivate has reshaped into a roughly US$2b revenue company with about 93% recurring organic revenue after selling lower margin and more transactional operations, which can support steadier revenue and earnings quality as the subscription mix increases over time.
See why 5 investors see Clarivate as 21% undervalued.
Result: Fair Value of $3.04 (UNDERVALUED)
Still, Clarivate relies heavily on higher education budgets and faces pressure from lower-cost research tools, which could chip away at subscriptions and squeeze future margins.
Find out about the key risks to this Clarivate narrative.
Next Steps
Curious whether this mix of pressure and potential at Clarivate points to a turnaround or a value trap, given the competing views on its outlook? Act quickly and review the full picture of concerns and upsides in the 4 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Clarivate?
Do not stop with Clarivate. Use fresh stock ideas from focused lists so you are not leaning on a single turnaround story.
- Target future upside by scanning a curated pool of quality opportunities that currently trade below estimated worth through the 36 high quality undervalued stocks.
- Strengthen the downside protection in your portfolio by filtering for companies that pass balance sheet and fundamentals checks with the list of solid balance sheet and fundamentals (24 results).
- Get ahead of the crowd by reviewing a focused collection of under-followed businesses with strong metrics using the 20 high quality undiscovered gems.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com